Pharmaceutical stocks and drugmakers are theoretically recession-proof
businesses, since folks will do everything they can to maintain their quality of
life through medication and treatments. Still, not all pharma companies are
created equal and there are clear winners and losers in this health care sector.
I watch more than 5,000 publicly traded companies with my Portfolio Grader tool,
ranking companies by a number of fundamental and quantitative measures. This
week Ive got seven pharma stocks to sell. Here they are, in alphabetical order.
Each one of these stocks gets a "D" or "F" according to my research,
meaning it is a "sell" or "strong sell." Auxilium Pharmaceuticals Inc.
(NASDAQ: AUXL ) develops and markets products for urologists, endocrinologists,
hand surgeons and other specialty physicians. AUXL has had a 23% slide,
year-to-date. Endo Pharmaceuticals (NASDAQ: ENDP ) deals with branded products,
generics, devices and services, and is the developer of branded drugs you may
recognize such as Percocet and Lidoderm.
No comments:
Post a Comment